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Abstract
Until October 2005, surgery were performed for 76 intractable temporal lobe epilepsy patients. Among
them, 56 patients had follow-up of 12-76 months. The patients consisted of 35 males and 21 females,
age between 3-38 year-old. Magnetic Resonance Imaging diagnoses were hippocampal sclerosis in 50
patients, temporal lobe tumor in 3 patients, hemispheric hemiatrophy, calcified hippocampal lesion and
normal imaging one patient each. Intracranial subdural grid EEG was performed in the patient with
normal imaging. Psychological evaluation was performed in all patients, while Wada test was
performed on patients with left-sided lesion. All patients underwent anterior temporal lobectomy.
Seizure free (Engel’s I) was seen on 46 patients (82%). Six patients (11%) had less than 2 seizures per
year (Engel’s II). Seizure decreased by more than 75% (Engel’s III) in 4 patients (7%). There was a
trend with increased number of patients with Engel’s II and III with longer duration of seizures.
Complications were extradural empyema in 5 patients (9%), depression in 2 patients (4%), transient
hemiparesis in one patient (2%). Thirty-one patients were able to withdraw the antiepileptic drugs.
In conclusion, epilepsy surgery can achieve good results in developing countries.
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INTRODUCTION
Despite availability of modern antiepileptic drugs
(AEDs), up to 30-40% of epilepsy patients
continue to have seizures1,2 and approximately
half of these are potential candidates for surgery.3
Complex partial seizures with seizure focus mostly
in the temporal lobe made up most of these
intractable cases.4 Surgery to abolish seizures is
recommended for mesial temporal lobe epilepsy
(MTLE), which is possibly the most common
form of human epilepsy and the most refractory
to AEDs.5-7 Approximately 65% of patients are
seizure free after surgery, while another 21%
improved.8,9 The first randomized controlled trial
on patient with refractory epilepsy10 has shown
that in TLE, surgery is superior to optimized
AED therapy, with more than 64% seizure free
with surgery, and 8% with medical therapy.
In TLE the surgical procedure is a standardized
anterior temporal lobectomy including amygdalo-
hippocampectomy. All pre-surgical evaluation is
directed to determining the epileptogenic temporal
lobe. Magnetic resonance imaging (MRI) is
currently the best imaging modality for patient
with partial epilepsy.11-14 Visual MRI is able to
identify mesial temporal sclerosis (MTS) in 80-
90% of patients, and nearly 90% patients will be
seizure free after anterior temporal lobectomy.15-
19 Quantitative MRI studies, showing unilateral
volume loss, further improves the sensitivity of
detecting epileptogenic temporal lobe.20,21 The
volumetric MRI is particularly useful in patients
with  bilateral hippocampal atrophy, subtle
unilateral atrophy, and symmetric appearing
hippocampi.21,22
Assuming an epilepsy prevalence rate similar
to elsewhere at 0.5%, there are 1.1 million
Indonesians with epilepsy in the 220 million
populations, 276,000 to 386,000 are likely to be
refractory to AEDs, and 138,000 to 193,000 may
benefit from surgery.
Epilepsy surgery started on July 1999 at
Diponegoro University Hospital in Semarang,
Central Java, Indonesia. Since then, surgery has
been performed on 84 patients, partial epilepsy in
78 and generalized epilepsy in 6. Among partial
epilepsy cases, 76 were TLE receiving a standard
anterior temporal lobectomy and 56 of them had
follow-up of more than 12 months. This is a
review of the 56 patients.
METHODS
All the 56 patients had at least one 0.5T MRI
evaluation and interictal scalp EEG. Subdural
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grid EEG was performed in one patient where
MRI was unable to lateralize the lesion.
Psychological evaluation was performed in all,
while Wada test was performed in those with left-
sided lesion. All patients with MTLE underwent
anterior temporal lobectomy with amygdalo-
hippocampectomy. The results were evaluated
based on Engel’s Outcome Scale as follows:
Class Ia: Seizure free; Class Ib: aura only; Class
II: Not more than 2 attacks per year; Class III:
Seizure frequency decreases > 75% per year; and
Class IV: Seizure frequency decreases < 75% per
year.23 Surgery was regarded as beneficial for
patients in Engel’s Class I-III.4,24 Improvements
in socialization was based on reports by family
members. The surgery was performed by the
author. AEDs were continued postoperatively.
For those with Engel’s Class I, the AEDs were
tapered after six months.
RESULTS
Of the 56 patients, there were 35 males and 21
females. The age ranged from 3 to 38 years. Most
patients (70%) were less than 30 year-old, while
82% had the disease for less than 20 years. Figure
1 shows the age distribution and length of epilepsy
before surgery. Twenty patients (36%) were high
school or university graduates, while 12 patients
(21%) were still at intermediate or high school.
All patients had complex partial seizures with or
without secondary generalization. MRI diagnoses
were hippocampal sclerosis in 50, temporal lobe
tumor in 3 consisting of dysembryoplastic
neuroepithelial tumor in lateral neocortex in 2
and pleomorphic xantho-astrocytoma of the
hippocampus in one; hemispheric hemiatrophy,
calcified hippocampal lesion, and normal MRI
one patient each. The 30 minutes routine scalp
EEG in 40 seizure-free patients showed bilateral
epileptiform activity in 60%, ipsilateral activity
in 35%, and contralateral activity in 5%. The
seizure frequency was 1-10 per month despite 3-
4 AEDs in combination. The operations were on
the right side in 38 patients (all were right handed),
and left side in 18. The patients underwent anterior
temporal lobectomy with amygdalo-
hippocampectomy, except the 2 cases with
dysembryoplastic neuroepithelial tumor who had
only anterior temporal lobectomy.
Engel’s Ia was seen in 41 patients (73%),
Engel’s Ib in 5 patients (9%), Engel’s II in 6
patients (11%), and Engel’s III in 4 patients (7%).
Cross analysis showed that number of Engel’s II
and III tend to increase as the duration of the
disease is increasing. Figure 2 shows the result of
surgery in relation to the length of disease before
surgery. All patients were better socialized,
especially the younger and the highly educated.
Many restarted school after quitting for some
time. The complications were: Depression needing
psychiatric referral (2), transient hemiparesis that
resolved in 3 months (1). Surgical complications
were extradural empyema that required bone flap
removal (5). Most patients required less AEDs,
while AEDs could be totally withdrawn in 31
patients (55%). Even with seizure freedom, some
patients preferred to continue with at least one
AED. Of the 46 Class I patients, AEDs could be
totally withdrawn in 31 (70%). Figure 3 shows
the number of patients who achieved Engel’s I,
and those whose AEDs can be withdrawn, in
relation to duration of disease before surgery. As
shown the proportion of patients whose AEDs
can be totally withdrawn is higher in those with
shorter duration of disease before surgery. Forty
of our patients had follow-up of 24 months or
more. Among them, 33 (83%) achieved Engel’s
Class I.
DISCUSSION
We depended on MRI to localize the epileptogenic
focus in all but one patient. Zentner et al4 has
shown that MRI’s sensitivity reaches 98.7% for
neoplastic lesions, 76.6% for non-neoplastic
lesions such as cavernous malformation, and
69.2% for MTS / hippocampal sclerosis. Its
specificity reaches 87% for neoplastic lesions,
53% for MTS / hippocampal sclerosis, and 34%
for others.
We performed 30 minutes routine scalp EEG
to look for interictal discharges. Bilateral and
even contralateral interictal discharges were not a
contraindication for surgery. Our own observation
was that only 35% had interictal discharges
ipsilateral or concordant with the MRI lesions,
60% showed bilateral foci, and another 5%
showed contralateral foci. This is consistent with
previous findings, that in good outcome after
unilateral ATL, bilateral interictal discharges in
routine EEG is common.25-28 Lateralized interictal
discharges is seen only in 41% patient.29 The
reason for the ‘mirror’ focus is the tendency of an
actively discharging epileptiform region to induce
similar paroxysmal behavior in the homologous
contralateral side.30 Interictal discharges may
incorrectly lateralize the temporal foci in 10-20%
patients.18,19,31 The discharges from medial
temporal lobe may have propagated to the lateral
cortex of the opposite sides resulting in incorrect
localization.32,33 Using scalp-sphenoidal, ictal
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Figure 1:  Age distribution and length of epilepsy before surgery in 56 TLE patients.
















Figure 3: Graph showing the number of patients who achieved Engel’s I, and those whose AEDs can withdrawn,
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vido-EEG recording, accurate localization is
possible in 65-70% of TLE patients.34 We hope a
video-EEG monitoring service can soon be
established in our Center to improve our selection
of patients. We performed subdural grid EEG in
one patient with doubtful MRI laterality, while
routine scalp EEG showed bilateral interictal
discharges. The result clearly showed right-sided
focus, and surgery was then performed.
Engel’s Outcome Scale23 is the most widely
used reference for the results of epilepsy surgery.
According to Engel’s criteria, all of our patients
were Class I to III, all benefited from the surgery.
Those with Engel’s Class I gained most from the
operation, and 82% of our patients are in this
group. Our result is consistent with others, where
65-75% achieve seizure freedom after anterior
temporal lobectomy with amygdalo-
hippocampectomy, another 20% has meaningful
improvement.23,35-39 Wyler AR24 reported that
seizure free probability reached 90% after one
year, and increased to 94% after two years.
Evaluation at the end of 2nd postoperative year is
thus a good predictor of the long-term seizure
outcome. Of our patients with 2 years follow up,
83% were in Engel’s Class I.
Recent advances has elucidated several
biological basis for refractoriness, such as the
presence of certain structural abnormalities,
particularly MTS / hippocampal sclerosis and
cortical dysplasia.40-42 In a recent long term study
of newly diagnosed epilepsy, the probability of
achieving seizure-free declined rapidly and
progressively after the first two monotherapy
treatment.2,43,44 Many adult epilepsy centers define
medical intractability as persistent seizures despite
2 years and 2 maximally tolerated AEDs.45-47
thus, all patients with partial epilepsy who fail
two AEDs, and in patient with resectable brain
abnormality, particularly hippocampal sclerosis
and cortical dysplasia, should be considered for
epilepsy surgery. Our studies has shown that
epilepsy surgery can acheve good results in
developing countries with limited resources, as
also reported by Chinvarun48 and Srikijvilaikul49
from Thailand, and Panda from south India.50
Delay in surgery results in psychosocial,
educational, and vocational problems which are
difficult to overcome even though the seizures
have been eliminated by surgery.51,52 Such delay
with “lost of years” is no longer acceptable.53,54
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